Summary by Ground NewsThe provision is known as skinny labeling, which refers to a move by a company that seeks regulatory approval to market a generic or biosimilar medicine. By doing so, the company seeks to avoid lawsuits in which the brand-name manufacturer could claim patent infringement. Medicare saved $1.5 billion from 2015 to 2020, or nearly 5% of the $30.2 billion spent by the health care program.
Published 2 months ago
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Time & Location
Sources are mostly out of (0)